Navigation Links
Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
Date:9/4/2007

Termination of Negotiation with Carticept for Commercialization and

Distribution of Products for the Professional Medical Market

LIVINGSTON, N.J., Sept. 4 /PRNewswire-FirstCall/ -- Milestone Scientific, Inc. (OTC Bulletin Board: MLSS) today announced that it has successfully concluded its Collaboration Agreement with Carticept Medical Inc. for the development of an injection system based on Milestone's CompuFlo(TM) technology for the treatment of arthritic joints. Work under the Collaboration Agreement, including animal studies, demonstrated to Carticept's satisfaction that the prototype could meet its predetermined performance benchmarks, leading the parties to commence negotiations for the development of a commercial product and for a Distribution Agreement between Milestone and Carticept. However, the parties have been unable to reach agreement on required minimum purchases by Carticept, the territories to be covered by the Distribution Agreement, development time tables for foreign territories and other matters and have, therefore, terminated negotiations.

"We are pleased that work under the Collaboration Agreement, particularly the animal studies, provided further evidence of the benefits of our CompuFlo(TM) technology to inject hyaluronic acid and other medicaments into the interarticular joint space for the treatment of arthritic conditions," said Joe Martin, Chief Executive Officer of Milestone Medical. Martin added, "We are a bit disappointed that we were unable to reach a commercialization agreement with Carticept. However, this is a large market, estimated at more than $21 billion, and we intend to explore new opportunities for our CompuFlo(TM) technology in this area." With the conclusion of negotiations with Carticept, Milestone is now free to explore other opportunities in this market with larger entities holding established positions in the field.

About Milestone Scientific, Inc.

Headquartered in Livingston, N
'/>"/>

SOURCE Milestone Scientific, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Cancer Research: Yet Another Milestone
2. Year 2010 Envisioned to be Milestone Year for Malaria Vaccine
3. Eurand and GSK Reach Development Milestone
4. A New Milestone in Stem Cell Research
5. Scientific markers of aging described
6. A Settlement Over Stem Cell Controversy Through Scientific Research
7. A Scientific Explanation For Out Of Body Experience
8. PUFA Good For Heart: Gets The Scientific Seal
9. Forensic Phonetics – Scientific Solution for Legal Problem
10. Old Indian Advice Has A Scientific Backing Now!
11. India To Highlight Its Scientific Achievements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... up to 50 percent savings on medical services and ...lleville, Ill. (Vocus) October 6, 2008 -- Allsup a...sup.com/Health-Discount-Program.aspx/?=PRJ2 [Healt...am] to help millions of people with disabilities g...rvices. The program is among the new financial and...
(Date:10/5/2008)...rug samples distributed to children may be unsafe,... Health Alliance and Hasbro Children,s Hospital. T...sample use among children, appears in the October ...also serve as researchers at Harvard Medical Schoo...iversity, found that children commonly receive fre...
(Date:10/5/2008)... a long way toward helping severely obese individu...ortant daily tasks, according to researchers at th...am assessment where patients reported, on average,...uals who were more active reported better overall-...n their ability to perform daily tasks as measured...
(Date:10/3/2008)...ities Named In Wash. Lawsuit, SEATTLE, Oct. 3 /PR...dditional allegations in the class action lawsuit ...ts 16 facilities in the state of Washington [see,l...e #2:08-cv-01332-JCC) in,United States District Co...e original complaint (Case #08-2-28645-2KNT), file...
Breaking Medicine News(10 mins):Health News:Allsup Introduces Health Discount Program to Millions of People with Disabilities 2Health News:Allsup Introduces Health Discount Program to Millions of People with Disabilities 3Health News:Free drug samples carry risks for children 2Health News:A little exercise goes a long way for severely obese 2Health News:Additional Allegations Filed Against Elder Care Operator 2Health News:Additional Allegations Filed Against Elder Care Operator 3Health News:Additional Allegations Filed Against Elder Care Operator 4Health News:Additional Allegations Filed Against Elder Care Operator 5
...lication that affects up to 25 percent of lung tra...s// a significant risk factor for later deadly bro...rch appears in the first issue for March 2007 of t...d Critical Care Medicine, published by the America...
... employees to order prescription drugs through the...y think they are//. In recent years, mail-order p...s), have become popular among cost-conscious compa... their employees. Their belief – supported by a 20...
...tists to create part-animal and part-human only fo...ses//. This was announced by the health minister C... on fertility treatment and embryo research. Perm... scientists who are desirous of creating cybrid em...
... come out with a cheap and effective drug for mala...tion with the Drugs// for Neglected Diseases initi...ncy Medecins Sans Frontieres (MSF). This treatment...sunate and amodiaquine. The earlier treatment for...
Other Medicine News:Health News:Primary Graft Dysfunction Is Risk Factor For Lung Transplant Problem 2Health News:Mail-Order Drugs: Deal or No Deal? 2
(Date:10/6/2008)...Scheduled for 9:00 AM ET Today -, SEATTLE, Oct. 6...asdaq:,DNDN) announced today that it has completed...omized, double-blind, placebo-controlled IMPACT,(I..., also known as D9902B),clinical trial designed to...onal active cellular immunotherapy PROVENGE(R) (si...
(Date:10/6/2008)...drinking polyphenol-rich 100% Concord grape,juice ...y intake or body,weight, CONCORD, Mass., Oct. 6 /...nol-rich Concord grape juice did not cause signifi...in appetite and was shown to reduce waist,circumfe...Annual Meeting of,the American College of Nutritio...
(Date:10/3/2008)...Kinase Inhibitors for Cancer Treatments, INDIANAP...FirstCall/ --,Eli Lilly and Company (NYSE: LLY ) ...today announced that the two companies have entere...eement related to,Deciphera,s preclinical B-Raf ki...oncology therapeutics., The collaboration will ap...
(Date:10/2/2008)... /- Calabar AB announced today,that t...dry mouth"),patients has been initiated. Specifica...ents between the ages of 20 to 75. The objective o...a succeeding Phase III efficacy,study., Xalieve(T...r,physostigmine. It is administered locally in the...
Breaking Medicine Technology:Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Use it or Lose it 3A A New Theory About Preserving Erectile Function After Prostate Surgery 49 1Use it or Lose it 3A A New Theory About Preserving Erectile Function After Prostate Surgery 49 2Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine 46 1Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine 46 2Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine 46 3Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine 46 4Abbott Receives Supplemental FDA Approval for its Best in Class in Sensitivity RealTime HIV 1 Viral Load Test 43 1Abbott Receives Supplemental FDA Approval for its Best in Class in Sensitivity RealTime HIV 1 Viral Load Test 43 2Abbott Receives Supplemental FDA Approval for its Best in Class in Sensitivity RealTime HIV 1 Viral Load Test 43 3Abbott Receives Supplemental FDA Approval for its Best in Class in Sensitivity RealTime HIV 1 Viral Load Test 43 4Abbott Receives Supplemental FDA Approval for its Best in Class in Sensitivity RealTime HIV 1 Viral Load Test 43 5Abbott Receives Supplemental FDA Approval for its Best in Class in Sensitivity RealTime HIV 1 Viral Load Test 43 6Solvay Pharmaceuticals Inc and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox an Investigational Treatment for Schiz 40 1Solvay Pharmaceuticals Inc and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox an Investigational Treatment for Schiz 40 2Solvay Pharmaceuticals Inc and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox an Investigational Treatment for Schiz 40 3
OCD-3000 pnuematic conserving regulator for large cylinder.
OCD-3000 pnuematic conserving regulator.
...ing an oxygen conserver, it's important to have a ...lied, a name synonymous with innovative excellence...ade; and Mini Liberty™, two totally automati...AA battery, the Mini Liberty can be used 8 hours a...
OCD-2000 electronic conserving regulator.
Medicine Products: